China Pharma Holdings CPHI
NYSE CPHI
$0.64 -0.02 (-2.62%)
As of: Oct 1, 2026 · 3:53 PM EDT

China Pharma Holdings (CPHI) Selling, General & Administrative (2010 - 2026)

Updated

China Pharma Holdings' Selling, General & Administrative was $1.38 million in Q2 2026, up 212.4% from $440,834 a year earlier and up 12.3% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, China Pharma Holdings' Selling, General & Administrative was $4.11 million through Jun 30, 2026, up 90.8% year-over-year; for FY2025, it was $2.45 million, up 37.4% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $1.78 million in FY2024 (+21.7%), $1.47 million in FY2023 (-22.6%), $1.89 million in FY2022 (+14.7%) and $1.65 million in FY2021 (-9.4%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q2 2013.
  • Compared with a year earlier, Selling, General & Administrative has increased for eight straight quarters, with growth averaging 106.4% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q2 2025 (growth of 379.8%); the worst was Q2 2023 (a decline of 59.0%).
  • Per Business Quant data, CPHI's Selling, General & Administrative in the three quarters before Q2 2026 was $1.23 million (Q1 2026), $1.08 million (Q4 2025) and $424,827 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 China Pharma Holdings 26.34 Mn 25.22 Mn 83,566.00 1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.38 Mn
Mar 31, 2026 1.23 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 424,827.00
Jun 30, 2025 440,834.00
Mar 31, 2025 507,182.00
Dec 31, 2024 859,373.00
Sep 30, 2024 345,051.00
Jun 30, 2024 91,870.00
Mar 31, 2024 488,456.00
Dec 31, 2023 689,785.00
Sep 30, 2023 246,267.00
Jun 30, 2023 112,033.00
Mar 31, 2023 417,999.00
Dec 31, 2022 829,434.00
Sep 30, 2022 276,611.00
Jun 30, 2022 273,056.00
Mar 31, 2022 514,168.00
Dec 31, 2021 610,298.00
Sep 30, 2021 301,970.00
API Access

China Pharma Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CPHI&period=max&api_key=YOUR_API_KEY